Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (231-240 of 481) with videos related to

Pageof 49
Sort By:
Radiology|August 22, 2007
Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experienceArpi Thukral, David M Thomasson, Catherine K Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapyThomas S Uldrick, Kathleen M Wyvill, Pallavi Kumar, et al.
Molecular Cancer Therapeutics|January 12, 2008
Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxelTristan M Sissung, Romano Danesi, Douglas K Price, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2013
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunityJianping Huang, Caroline Jochems, Austin M Anderson, et al.
Cancer Biology & Therapy|October 14, 2009
Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomasSherry X Yang, Shivaani Kummar, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinomaElizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Neuro-Oncology|August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromasRegina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
The Journal of Urology|July 12, 2005
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancerPhilip M Arlen, James L Gulley, Nushin Todd, et al.
Lancet (London, England)|February 28, 2002
Use of proteomic patterns in serum to identify ovarian cancerEmanuel F Petricoin, Ali M Ardekani, Ben A Hitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancerChia C Portera, Janice M Walshe, Douglas R Rosing, et al.
Pageof 49

Showing results (231-240 of 481) with videos related to

Sort By:
Pageof 49
Radiology|August 22, 2007
Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experienceArpi Thukral, David M Thomasson, Catherine K Chow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapyThomas S Uldrick, Kathleen M Wyvill, Pallavi Kumar, et al.
Molecular Cancer Therapeutics|January 12, 2008
Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxelTristan M Sissung, Romano Danesi, Douglas K Price, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2013
Soluble CD27-pool in humans may contribute to T cell activation and tumor immunityJianping Huang, Caroline Jochems, Austin M Anderson, et al.
Cancer Biology & Therapy|October 14, 2009
Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomasSherry X Yang, Shivaani Kummar, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinomaElizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Neuro-Oncology|August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromasRegina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
The Journal of Urology|July 12, 2005
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancerPhilip M Arlen, James L Gulley, Nushin Todd, et al.
Lancet (London, England)|February 28, 2002
Use of proteomic patterns in serum to identify ovarian cancerEmanuel F Petricoin, Ali M Ardekani, Ben A Hitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancerChia C Portera, Janice M Walshe, Douglas R Rosing, et al.
Pageof 49